Sandoz Group AG (SDZ)
SIX
Real-time Data
07:00 AM
Day's Range
73.1852 wk Range
43.86Overview - SDZ - Sandoz Group AG
Key Statistics
Valuation
Enterprise Value
28.80B
P/E (Trailing)
‪63.11‬
P/E (Forward)
‪20.25‬
PEG Ratio
‪20.25‬
Price / Sales (TTM)
‪2.73‬
Price / Book
‪4.47‬
EV / EBITDA
‪22.90‬
Profitability
Profit Margin
‪5.53%‬
Operating Margin
‪4.25%‬
Return on Assets
‪3.06%‬
Return on Equity
‪7.24%‬
Ownership
Shares Outstanding
432.69M
Float
416.43M
Held by Insiders
‪4.18%‬
Held by Institutions
‪50.56%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪69.10‬
200-Day Avg
‪63.91‬
Dividends
Payout Ratio
‪68.81%‬
Frequency
Annual
Analyst Consensus
16 analysts
Average price target
‪CHF 71.39‬Market Cap - SDZ - Sandoz Group AG
Peers - SDZ - Sandoz Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SIX.
Profile Summary - SDZ - Sandoz Group AG
About
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patients worldwide. The company develops, manufactures, and commercializes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
